SCHEMBL6448261

SCHEMBL6448261

[c]1ccccc1Oc1ccncc1

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.33
LTA4H P09960 2/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
HTT P42858 1/20 0.30
MMP13 P45452 1/20 0.30
MAPK14 Q16539 1/20 0.30
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL76698 0.83 LTA4H (0.50) LTA4HTSHRKDM4EGLAMAPT
Water SCHEMBL27530954 0.81 LTA4H (0.48) LTA4HTSHRKDM4EGLAMAPT
SCHEMBL28770243 0.81 LTA4H (0.48) LTA4HTSHRKDM4EGLAMAPT
SCHEMBL8126838 0.79 LMNA (0.52) LTA4HSMN1; SMN2LMNAHTT
SCHEMBL8535180 0.79 LTA4H (0.52) LTA4HTSHRKMT2A
SCHEMBL152163 0.78 LTA4H (0.32) LTA4HTSHR
SCHEMBL1220986 0.76 LTA4H (0.54) LTA4HKMT2ALMNASLC6A2SLC6A3
SCHEMBL1930820 0.76 LTA4H (0.32) LTA4HTSHR
SCHEMBL1532042 0.76 ALDH1A1 (0.39) LTA4HKDM4EMAPTKMT2ALMNA
SCHEMBL2090470 0.76 LTA4H (0.54) LTA4HSMN1; SMN2MAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105228974-A Ethylene oligomerization becomes the oligomerization process of the mixture of 1-hexene and 1-octene SASOL TECH PTY LTD 2016-01-06 CN disclosed
EP-2875014-A2 ANTI-MUCUS DRUGS AND USES THEREFOR Washington University (US) 2015-05-27 EP disclosed
WO-2014015056-A2 ANTI-MUCUS DRUGS AND USES THEREFOR WASHINGTON UNIVERSITY (US) 2014-01-23 WO disclosed
EP-1244359-B1 COMBINATION OF FLUAZURON AND IVERMECTIN FOR PARASITE CONTROL NOVARTIS AG (CH) 2005-01-12 EP disclosed
US-6469067-B1 FOR TREATMENT OF LIVESTOCK FOR PARASITES; COMPRISES 1-(4-CHLORO-3-(3-CHLORO-5-TRIFLUOROMETHYL-2-PYRIDYLOXY) PHENYL)-3-(2,6-DIFLUOROBENZOYL)UREA AND ONE OF: IVERMECTIN, DORAMECTIN, MOXIDECTIN AND SELAMECTIN NOVARTIS AG (CH) 2002-10-22 US disclosed
EP-1244359-A1 COMBINATION OF N-PHENYL-N'-BENZOYL UREA DERIVATIVE AND NECTIN COMPOUNDS FOR PARASITE CONTROL Novartis AG (CH) 2002-10-02 EP disclosed
WO-2001037667-A1 COMBINATION OF N-PHENYL-N'-BENZOYL UREA DERIVATIVE AND NECTIN COMPOUNDS FOR PARASITE CONTROL NOVARTIS AG (CH) 2001-05-31 WO disclosed